Atrial Fibrillation, Pacemaker, Stroke
Conditions
Brief summary
To investigate the incidence, clinical characteristics and prognosis of acute ischemic and hemorrhagic cerebrovascular disease secondary to the implantation of cardiovascular implantable electronic devices, so as to provide a basis for subsequent treatment strategies and risk factor stratification. This study intends to retrospectively collect the incidence and case characteristics of acute cerebral infarction, cerebral embolism, transient ischemic attack and cerebral hemorrhage in CIED patients admitted to the First Affiliated Hospital of Xi 'an Jiaotong University and other centers from January 2012 to September 2022. Then, the incidence of poor prognosis and related factors of patients within 3 months were followed up by telephone to provide a basis for subsequent treatment strategy and risk factor stratification.
Interventions
DEVICEcardiac electronic implants
Cardiac electronic implants(CIED) includes permanent pacemaker (PPM), implantable cardioverter defibrillator (ICD), three-chamber pacemaker for cardiac resynchronization therapy defibrillator, lead free pacemaker, etc.
Sponsors
First Affiliated Hospital Xi'an Jiaotong University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Clinical diagnosis of acute cerebrovascular disease secondary to cardiac electronic device implantation. * Hospitalized from January 2012 to September 2022.
Exclusion criteria
* Patients were absent of cranial CT/MRI scan data. * Patients refuse to take follow-up interviews.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The incidence of acute cerebrovascular disease | About 4 weeks after the enrollment | Number and rate of patients with acute cerebrovascular disease secondary to patients receiving cardiac electronic implants. The data were obtained from the medical records. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| In-hospital mortality | About 4 weeks after the enrollment | In-hospital mortality of acute cerebrovascular disease in patients receiving cardiac electronic implants. The data were obtained from the medical records. |
| All-cause mortality | 3 months after the enrollment | All-cause mortality within 3 months of telephone follow-up. |
Countries
China
Outcome results
None listed